Table 4.
Clinical characteristics of HCWs
| Antispike IgG | |||||
|---|---|---|---|---|---|
| HCWs w/wo chronic diseases | COVID‐19 History No. (%) | Positive No. (%) | Median (AU/ml) | Minimum (AU/ml) | Maximum (AU/ml) |
| No chronic disease (n = 847) (79%) | PCR‐confirmed 210 (24.8) | 208 (99) | 8926.0 | 24.1 | 104 990 |
| Not infected 595 (70.2) | 436 (73.3) | 111.1 | 0.02 | 11 365 | |
| Chronic disease (n = 225) (21%) | PCR‐confirmed 67 (29.8) | 65 (97) | 1024.2 | 13.2 | 16152.5 |
| Not infected 151 (67.1) | 90 (59.6) | 71.4 | 0.3 | 8219 | |
| Antispike IgG | |||||
|---|---|---|---|---|---|
| HCWs w/wo immunosuppressive treatment | COVID‐19 History No. (%) | Positive No. (%) | Median (AU/ml) | Minimum (AU/ml) | Maximum (AU/ml) |
| Not immunsupp. (n = 1049) (97.9%) | PCR‐confirmed 269 (25.6) | 265 (98.5) | 909.1 | 13.2 | 104 990 |
| Not infected 732 (69.8) | 518 (70.8) | 101.8 | 0.02 | 11 365 | |
| Immunsupp. tx (n = 23) (2.1%) | PCR‐confirmed 8 (35.8) | 8 (100) | 2399.8 | 716.7 | 7614 |
| Not infected 14 (60.9) | 8 (57.1) | 53.8 | 5 | 668.7 | |
Abbreviations: COVID‐19, coronavirus disease‐2019; CT, computed tomography; HCW, healthcare worker; IgG, immunoglobulin G; SARS‐CoV‐2, severe acute respiratory syndrome coronavirus 2.